Gynov Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $573K

  • Investors
  • 1

Gynov General Information

Description

Developer of nutritional supplements designed to serve women's health. The company is involved in the scientific application of dietary supplements, using carefully selected ingredients through a multi-target, holistic approach, enabling women to access scientifically researched products during puberty, pregnancy, the postpartum period, and the peri- and post-menopause periods.

Contact Information

Website
www.gynov.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Rue Sauteyron
  • 33000 Bordeaux
  • France
+33 09
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 2 Rue Sauteyron
  • 33000 Bordeaux
  • France
+33 09

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gynov Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 26-Nov-2021 $573K Completed Generating Revenue
To view Gynov’s complete valuation and funding history, request access »

Gynov Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Gynov’s complete cap table history, request access »

Gynov Patents

Gynov Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3177937-A1 Compositions and combinations for subjects suffering from endometriosis Pending 19-May-2020
EP-4153203-A1 Compositions and combinations for subjects suffering from endometriosis Active 19-May-2020
EP-4153203-B1 Compositions and combinations for subjects suffering from endometriosis Active 19-May-2020
EP-4153203-C0 Compositions and combinations for subjects suffering from endometriosis Active 19-May-2020
ES-3013129-T3 Compositions and combinations for subjects suffering from endometriosis Active 19-May-2020 A61K36/064
To view Gynov’s complete patent history, request access »

Gynov Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gynov Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eure Kare VC-Backed Company Minority
To view Gynov’s complete investors history, request access »

Gynov FAQs

  • When was Gynov founded?

    Gynov was founded in 2016.

  • Where is Gynov headquartered?

    Gynov is headquartered in Bordeaux, France.

  • What is the size of Gynov?

    Gynov has 7 total employees.

  • What industry is Gynov in?

    Gynov’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Gynov a private or public company?

    Gynov is a Private company.

  • What is the current valuation of Gynov?

    The current valuation of Gynov is .

  • What is Gynov’s current revenue?

    The current revenue for Gynov is .

  • How much funding has Gynov raised over time?

    Gynov has raised $573K.

  • Who are Gynov’s investors?

    Eure Kare has invested in Gynov.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process